0001209191-17-054484.txt : 20171002
0001209191-17-054484.hdr.sgml : 20171002
20171002140113
ACCESSION NUMBER: 0001209191-17-054484
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170928
FILED AS OF DATE: 20171002
DATE AS OF CHANGE: 20171002
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RINGO WILLIAM R
CENTRAL INDEX KEY: 0001238325
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36070
FILM NUMBER: 171114008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC
CENTRAL INDEX KEY: 0001175505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260038620
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-365-5600
MAIL ADDRESS:
STREET 1: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-09-28
0
0001175505
FIVE PRIME THERAPEUTICS INC
FPRX
0001238325
RINGO WILLIAM R
TWO CORPORATE DRIVE
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Common Stock
2017-09-28
4
M
0
2000
11.65
A
2000
D
Common Stock
2017-09-28
4
S
0
2000
38.00
D
0
D
Stock Option (right to buy)
11.65
2017-09-28
4
M
0
2000
0.00
D
2024-09-30
Common Stock
2000
19000
D
The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on April 15, 2016.
The shares underlying this option vest at a rate of one-third per year on each anniversary of October 1, 2014.
/s/ Francis Sarena, Attorney-in-Fact
2017-10-02